Viridian Therapeutics
VRDN
VRDN
176 hedge funds and large institutions have $1.23B invested in Viridian Therapeutics in 2025 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 67 increasing their positions, 55 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
176
Holders Change
-2
Holders Change %
-1.12%
% of All Funds
2.39%
Holding in Top 10
8
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-33.33%
% of All Funds
0.11%
New
26
Increased
67
Reduced
55
Closed
27
Calls
$1.85M
Puts
$941K
Net Calls
+$908K
Net Calls Change
+$11.5M
Top Buyers
| 1 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$18.5M |
| 2 |
CC
Commodore Capital
New York
|
+$16.2M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$14.6M |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$11.6M |
| 5 |
EP
Eversept Partners
New York
|
+$8.06M |
Top Sellers
| 1 |
CCM
Cutter Capital Management
New York
|
-$12.1M |
| 2 |
PA
Perceptive Advisors
New York
|
-$11.1M |
| 3 |
State Street
Boston,
Massachusetts
|
-$8.86M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$8.81M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$8.16M |
